Diabetes: Effective Relief for Nerve Pain Steps Closer

Drugs that block a protein called HCN2 may have the potential to provide much-needed relief for people with diabetes who live with chronic nerve pain. So concludes a study led by researchers from King's College London in the United Kingdom, published in the journal Science Translational Medicine. The Growing Global Challenge Diabetes is a long-lasting condition that arises when the body either cannot produce enough insulin or cannot effectively use what it creates—a vital hormone that enables cells to convert blood sugar into energy. The global burden of diabetes continues to escalate rapidly: 1980: 4.7% of adults worldwide (108 million people) 2014: 8.5% of adults worldwide (422 million people) Understanding Diabetic Nerve Pain Many individuals living with the condition develop diabetic nerve pain—a chronic disorder resulting from diabetic neuropathy, which is nerve damage caused by prolonged high blood sugar levels. The condition presents a complex range of severe symptoms, including: Sharp, shooting pains Persistent tingling and prickling sensations Extreme sensitivity to physical touch These symptoms typically originate in the hands and feet before gradually spreading upward into the arms and legs. Breaking the Vicious Cycle The severity of the pain often severely impairs mobility. This reduced physical activity frequently leads to weight gain, which in turn worsens the broader health impacts of diabetes—creating a challenging vicious cycle for patients. The discovery of targeted treatments, such as HCN2 protein blockers, offers a promising step forward in breaking this cycle.